UK has upped the investment in order to become the ‘science superpower’
Taking the company Wild Bioscience, formed by Ross Hendron which works on projects at the intersection between molecular and computational biology. He explains : “Farmer’s are are the forefront of climate change and we’re giving them the tools to sustainably feed the planet population.” This is one of the hundred of life sciences and biotech companies.
George Freeman, expresses his mission to shift UK as being the academic powerhouse to a science superpower. The decision by the government to scale back its research and development tax credit scheme in the last budget was condemned by the biotech industry in particular, whose members have relied on this incentive to grow. The government, as a result, has committed to an increase in public research funding to £22bn a year by 2024-25, and a significant proportion is expected in life sciences.
Is this decision going to benefit the British economy?